Resource library


See all videos


Tumor Assessment Using RECIST 1.1 Criteria and Alternative Criteria for Immuno-oncology Trials

See all brochures

White papers

Understanding Novel Response Patterns of Immunotherapies

Immunotherapies display novel response patterns that affect the design of imaging based studies and the subsequent evaluation of imaging data. Applying traditional chemotherapy-based response assumptions to immunotherapy trials can result in inaccurate interpretation of response, premature therapy termination, and unnecessary removal of subjects from a trial. Our unique solutions for medical image analysis and management and iBiopsy® for imaging phenotyping, together with our global team of experts, are advancing the development of new drugs and diagnostic tools to monitor disease and assess response to therapy.

See all white papers

Case studies

FDA Inspection

See all case studies

Scientific publications

Fully-Learned Features for Lung Cancer Overall Survival Prediction

Danny Francis [1], Vladimir Groza [1], Benoit Huet [1], Nozha Boujemaa [1] – Affiliations: [1] Median Technologies, Valbonne, France.

This work presents an end-to-end trained method and its preliminary results demonstrating the possibility to predict Overall Survival (OS) time for patients with lung cancer.

See all scientific publications